TAK-242 in Patients With Acute Alcoholic Hepatitis

Clinical trial NCT04620148 · UNKNOWN

Trial details

NCT number: NCT04620148
Sponsor: Akaza Bioscience Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute-On-Chronic Liver Failure

Start date: 2021-12-01
Primary completion: 2022-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.